vs
Side-by-side financial comparison of DIODES INC (DIOD) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
DIODES INC is the larger business by last-quarter revenue ($391.6M vs $384.8M, roughly 1.0× P3 Health Partners Inc.). DIODES INC runs the higher net margin — 2.6% vs -19.6%, a 22.2% gap on every dollar of revenue. On growth, DIODES INC posted the faster year-over-year revenue change (15.4% vs 3.8%). Over the past eight quarters, DIODES INC's revenue compounded faster (13.9% CAGR vs -0.5%).
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
DIOD vs PIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $391.6M | $384.8M |
| Net Profit | $10.2M | $-75.5M |
| Gross Margin | 31.1% | — |
| Operating Margin | 3.4% | -40.0% |
| Net Margin | 2.6% | -19.6% |
| Revenue YoY | 15.4% | 3.8% |
| Net Profit YoY | 23.8% | -28.8% |
| EPS (diluted) | $0.23 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $391.6M | $384.8M | ||
| Q3 25 | $392.2M | $345.3M | ||
| Q2 25 | $366.2M | $355.8M | ||
| Q1 25 | $332.1M | $373.2M | ||
| Q4 24 | $339.3M | $370.7M | ||
| Q3 24 | $350.1M | $362.1M | ||
| Q2 24 | $319.8M | $379.2M | ||
| Q1 24 | $302.0M | $388.5M |
| Q4 25 | $10.2M | $-75.5M | ||
| Q3 25 | $14.3M | $-31.6M | ||
| Q2 25 | $46.1M | $-20.4M | ||
| Q1 25 | $-4.4M | $-20.5M | ||
| Q4 24 | $8.2M | $-58.6M | ||
| Q3 24 | $13.7M | $-46.5M | ||
| Q2 24 | $8.0M | $-12.0M | ||
| Q1 24 | $14.0M | $-18.7M |
| Q4 25 | 31.1% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 33.7% | — | ||
| Q2 24 | 33.6% | — | ||
| Q1 24 | 33.0% | — |
| Q4 25 | 3.4% | -40.0% | ||
| Q3 25 | 3.0% | -12.8% | ||
| Q2 25 | 2.6% | -9.6% | ||
| Q1 25 | 0.4% | -10.2% | ||
| Q4 24 | 3.5% | -37.4% | ||
| Q3 24 | 6.2% | -29.5% | ||
| Q2 24 | 1.2% | -8.3% | ||
| Q1 24 | 4.3% | -11.3% |
| Q4 25 | 2.6% | -19.6% | ||
| Q3 25 | 3.6% | -9.1% | ||
| Q2 25 | 12.6% | -5.7% | ||
| Q1 25 | -1.3% | -5.5% | ||
| Q4 24 | 2.4% | -15.8% | ||
| Q3 24 | 3.9% | -12.8% | ||
| Q2 24 | 2.5% | -3.2% | ||
| Q1 24 | 4.6% | -4.8% |
| Q4 25 | $0.23 | $-23.08 | ||
| Q3 25 | $0.31 | $-9.67 | ||
| Q2 25 | $0.99 | $-6.23 | ||
| Q1 25 | $-0.10 | $-6.28 | ||
| Q4 24 | $0.18 | $-23.13 | ||
| Q3 24 | $0.30 | $-15.70 | ||
| Q2 24 | $0.17 | $-7.37 | ||
| Q1 24 | $0.30 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $377.0M | $25.0M |
| Total DebtLower is stronger | $25.7M | $228.4M |
| Stockholders' EquityBook value | $1.9B | $-155.2M |
| Total Assets | $2.4B | $656.6M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $377.0M | $25.0M | ||
| Q3 25 | $386.4M | $37.7M | ||
| Q2 25 | $327.3M | $38.6M | ||
| Q1 25 | $343.9M | $40.1M | ||
| Q4 24 | $316.1M | $38.8M | ||
| Q3 24 | $319.3M | $63.0M | ||
| Q2 24 | $273.9M | $73.1M | ||
| Q1 24 | $276.0M | $27.3M |
| Q4 25 | $25.7M | $228.4M | ||
| Q3 25 | $24.9M | $252.8M | ||
| Q2 25 | $26.4M | $182.0M | ||
| Q1 25 | $20.5M | $171.1M | ||
| Q4 24 | $20.7M | $108.9M | ||
| Q3 24 | $22.2M | $133.2M | ||
| Q2 24 | $20.3M | $133.1M | ||
| Q1 24 | $20.9M | $118.1M |
| Q4 25 | $1.9B | $-155.2M | ||
| Q3 25 | $1.9B | $-18.7M | ||
| Q2 25 | $1.9B | $44.5M | ||
| Q1 25 | $1.8B | $63.3M | ||
| Q4 24 | $1.8B | $75.9M | ||
| Q3 24 | $1.8B | $120.5M | ||
| Q2 24 | $1.8B | $166.8M | ||
| Q1 24 | $1.7B | $146.6M |
| Q4 25 | $2.4B | $656.6M | ||
| Q3 25 | $2.5B | $683.6M | ||
| Q2 25 | $2.5B | $731.6M | ||
| Q1 25 | $2.4B | $783.9M | ||
| Q4 24 | $2.4B | $783.4M | ||
| Q3 24 | $2.4B | $833.3M | ||
| Q2 24 | $2.4B | $892.8M | ||
| Q1 24 | $2.4B | $855.9M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | 4.09× | ||
| Q1 25 | 0.01× | 2.71× | ||
| Q4 24 | 0.01× | 1.43× | ||
| Q3 24 | 0.01× | 1.11× | ||
| Q2 24 | 0.01× | 0.80× | ||
| Q1 24 | 0.01× | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.1M | $-25.7M |
| Free Cash FlowOCF − Capex | $12.4M | — |
| FCF MarginFCF / Revenue | 3.2% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | 3.74× | — |
| TTM Free Cash FlowTrailing 4 quarters | $137.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.1M | $-25.7M | ||
| Q3 25 | $79.1M | $-15.4M | ||
| Q2 25 | $41.5M | $-16.6M | ||
| Q1 25 | $56.7M | $-33.5M | ||
| Q4 24 | $81.8M | $-57.2M | ||
| Q3 24 | $54.4M | $-22.6M | ||
| Q2 24 | $14.4M | $-10.2M | ||
| Q1 24 | $-31.1M | $-20.0M |
| Q4 25 | $12.4M | — | ||
| Q3 25 | $62.8M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $62.1M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-51.5M | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -17.1% | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 5.8% | 0.0% | ||
| Q3 24 | 4.3% | 0.0% | ||
| Q2 24 | 5.6% | 0.0% | ||
| Q1 24 | 6.7% | 0.0% |
| Q4 25 | 3.74× | — | ||
| Q3 25 | 5.54× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.93× | — | ||
| Q3 24 | 3.95× | — | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -2.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
